Long-circulating sterically stabilized liposomes in the treatment of infections

Methods in Enzymology

Volumn 391, Issue SPEC. ISS., 2005, Pages 228-260

  Bakker Woudenberg, Irma A J M ^a   Schiffelers, Raymond M ^a   Storm, Gert ^a   Becker, Martin J ^a   Guo, Luke ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; CYCLOPHOSPHAMIDE; FENTANYL CITRATE; FLUANISONE; GENTAMICIN; HYPNORM; LIPOSOME; MACROGOL; MACROLIDE; NALORPHINE; PENTOBARBITAL; POLY(ETHYLENE GLYCOL) DISTEAROYLPHOSPHATIDYLETHANOLAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; STREPTOMYCIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CIRCULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; ENCAPSULATION; HOSPITAL INFECTION; INFECTION; INFLAMMATION; KIDNEY INJURY; LIPID COMPOSITION; MEMBRANE FLUIDITY; MYCOSIS; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE;

BACTERIA (MICROORGANISMS);

EID: 13844271851     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)91014-8     Document Type: Article

References (69)

1. Abra R.M., Hunt C.A. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta. 666:1981;493-603
2. Allen T.M. A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim. Biophys. Acta. 640:1981;385-397
3. Allen T.M. Long circulating (sterically stabilized) liposomes for targeted drug delivery. Adv. Drug Deliv. Rev. 13:1994;285-309
4. Allen T.M. Liposomes. Opportunities in drug delivery. Drugs. 54:(Suppl. 4):1997;8-14
5. Allen T.M. Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs. 56:1998;747-756
6. Allen T.M., Hansen C. Pharmacokinetics of stealth versus conventional liposomes: Effect of dose. Biochim. Biophys. Acta. 1068:1991;133-141
7. Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta. 981:1989;27-35
8. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066:1991;29-36
9. Allen T.M., Hansen C.B., Lopes de Menezes D.E. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16:1995;267-284
10. Ames B.N., Dubin D.T. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 235:1960;769-775
11. Bakker-Woudenberg I.A.J.M. Liposomes in the treatment of parasitic, viral, fungal and bacterial infections. J. Liposome Res. 5:1995;169
12. Bakker-Woudenberg I.A.J.M., van den Berg J.C., Michel M.F. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 22:1982;1042-1050
13. Bakker-Woudenberg I.A.J.M., Lokerse A.F., Roerdink F.H. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition. J. Pharmacol. Exp. Ther. 251:1989;321-327
14. Bakker-Woudenberg I.A.J.M., Lokerse A.F., ten Kate M.T., Mouton J.W., Woodle M.C., Storm G. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J. Infect. Dis. 168:1993;164-171
15. Bakker-Woudenberg I.A.J.M., ten Kate M.T., Stearne-Cullen L.E.T., Woodle M.C. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue. J. Infect. Dis. 171:1995;938-947
16. Bakker-Woudenberg I.A.J.M., ten Kate M.T., Guo L., Working P., Mouton J.W. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 45:2001;1487-1492
17. Bartlett G.R.J. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1959;466-468
18. Becker M.J., Dams E. Th. M., de Marie S., Oyen W.J.G., Boerman O.C., Fens M.H.A.M., Verbrugh H.A., Bakker-Woudenberg I.A.J.M. Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats. Nucl. Med. Biol. 29:2002;177-184
19. Begg E.J., Barclay M.L. Aminoglycosides-50 years on. Br. J. Clin. Pharmacol. 39:1995;597-603
20. Boerman O.C., Laverman P., Oyen W.J.G., Corstens F.H.M., Storm G. Radiolabeled liposomes for scintigraphic imaging. Prog. Lipid Res. 39:2000;461-465
21. Ellis M., Spence D., de Pauw B., Meunier F., Marinus A., Collette L., Sylvester R., Meis J., Boogaerts M., Selleslag D., Krcmery V., von Sinner W., MacDonald P., Doyen C., VanderCam B. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin. Infect. Dis. 27:1998;1406-1416
22. Fielding R.M., Lewis R.O., Moon-McDermott L. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharm. Res. 15:1998;1775-1781
23. Fielding R.M., Moon-McDermott L., Lewis R.O., Horner M.J. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey. Antimicrob. Agents Chemother. 43:1999;503-509
24. Gabizon A., Papahadjopoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim. Biophys. Acta. 1103:1992;94-100
25. Gabizon A., Huberty J., Straubinger R.M., Price D.C., Papahadjopoulos D. An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex. J. Liposome Res. 1:1988;123-135
26. Gangadharam P.R.J., Ashtekar D.R., Flasher D.L., Düzgü neş N. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob. Agents Chemother. 39:1995;725-730
27. Gregoriadis G. "Liposomes as Drug Carriers. Recent Trends and Progress." 1988;John Wiley & Sons, New York
28. Haran G., Cohen R., Bar L.K., Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta. 1151:1993;201-215
29. Huang S.K., Martin F.J., Friend D.S., Papahadjopoulos D. Mechanism of Stealth Liposomes Accumulation in Some Pathological Tissues. Lasic D., Martin F. "Stealth Liposomes" 1995;119-125 CRC Press, Boca Raton, FL
30. Hwang K.J., Luk K.F., Beaumier P.L. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study. Proc. Natl. Acad. Sci. USA. 77:1980;4030-4034
31. Kedem O., Katchalsky A. Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. Biochem. Biophys. Acta. 27:1958;229-246
32. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237
33. Kumana C.R., Yuen K.Y. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs. 47:1994;902-913
34. Kurantsin-Mills J., Jacobs H.M., Siegel R., Cassidy M.M., Lessin L.S. Indium-111 oxine labeled erythrocytes: Cellular distribution and efflux kinetics of the label. Int. J. Rad. Appl. Instrum. B16:1989;821-827
35. Lasic D.D. "Liposomes: From Physics to Applications." 1993;Elsevier Science Publishers, Amsterdam
36. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: Lessons for drug delivery. Biochim. Biophys. Acta. 1239:1995;145-156
37. Laverman P., Dams E.T., Oyen W.J., Storm G., Koenders E.B., Prevost R., van der Meer J.W., Corstens F.H., Boerman O.C. A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J. Nucl. Med. 40:1999a;192-197
38. Laverman P., Boerman O.C., Oyen W.J.G., Dams E. Th. M., Storm G., Corstens F.H.M. Liposomes for scintigraphic detection of infection and inflammation. Adv. Drug Deliv. Rev. 37:1999b;225-235
39. Leenders A.C., de Marie S., ten Kate M.T., Bakker-Woudenberg I.A.J.M., Verbrugh H.A. Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis. J. Antimicrob. Chemother. 38:1996;215-225
40. Leenders A.C.A.P., van Etten E.W.M., Bakker-Woudenberg I.A.J.M. Zak O., Sande A. "Handbook of Animal Models of Infection" 1999;693-696 Academic Press, San Diego, CA
41. Meirinha da Cruz M.E., Ataide de Carvalhosa N.D., Gameiro Francisco A.P. 1993;. Patent no. WO9323015.
42. Mingeot-Leclercq M.P., Tulkens P.M. Aminoglycosides: Nephrotoxicity. Antimicrob. Agents Chemother. 43:1999;1003-1012
43. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA. 88:1991;11460-11464
44. Petersen E.A., Grayson J.B., Hersh E.M., Dorr R.T., Chiang S.M., Oka M., Proffitt R.T. Liposomal amikacin: Improved treatment of Mycobacterium avium complex infection in the beige mouse model. J. Antimicrob. Chemother. 38:1996;819-828
45. Pinto-Alphandry H., Andremont A., Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int. J. Antimicrob. Agents. 13:2000;155-168
46. Ruijgrok E.J., Vulto A.G., van Etten E.M. J. Liposome Res. 9:1999;291-300
47. Schiffelers R.M., Bakker-Woudenberg I.A.J.M., Snijders S.V., Storm G. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics. Biochim. Biophys. Acta. 1421:1999;329-339
48. Schiffelers R.M., Bakker-Woudenberg I.A.J.M., Storm G. Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: Dependence on circulation kinetics and presence of poly(ethylene)glycol coating. Biochim. Biophys. Acta. 1468:2000;253-261
49. Schiffelers R.M., Storm G., ten Kate M., Bakker-Woudenberg I.A.J.M. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. Antimicrob. Agents Chemother. 45:2001a;464-470
50. Schiffelers R., Storm G., Bakker-Woudenberg I. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J. Antimicrob. Chemother. 48:2001b;333-344
51. Schiffelers R.M., Storm G., Bakker-Woudenberg I.A.J.M. Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharm. Res. 18:2001c;780-787
52. Schiffelers R.M., Storm G., ten Kate M.T., Stearne-Cullen L.E., den Hollander J.G., Verbrugh H.A., Bakker-Woudenberg I.A.J.M. In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime. J. Pharmacol. Exp. Ther. 298:2001d;369-375
53. Senior J.H. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193
54. Silvander M., Johnsson M., Edwards K. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. Chem. Phys. Lipids. 97:1998;15-26
55. Storm G., Woodle M.C. Woodle M.C., Storm G. "Long Circulating Liposomes: Old Drugs, New Therapeutics" 1998;3-16 Springer-Verlag, Berlin
56. Storm G., Belliot S.O., Daemen T., Lasic D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 17:1995;31-48
57. Tollemar J., Klingspor L., Ringdén O. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children. Clin. Microbiol. Infect. 7:(Suppl. 2):2001;68-79
58. van Etten E.W.M., ten Kate M.T., Stearne L.E.T., Bakker-Woudenberg I.A.J.M. Amphotericin B liposomes with prolonged circulation in blood: In vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Antimicrob. Agents Chemother. 39:1995a;1954-1958
59. van Etten E.W.M., Otte-Lambillion M., van Vianen W., ten Kate M.T., Bakker-Woudenberg I.A.J.M. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. J. Antimicrob. Chemother. 35:1995b;509-519
60. van Etten E.W.M., van Vianen W., Tijhuis R.H.G., Storm G., Bakker-Woudenberg I.A.J.M. Sterically stabilized amphotericin B-liposomes: Toxicity and biodistribution in mice. J. Control. Rel. 37:1995c;123-129
61. van Etten E.W.M., Snijders S.V., van Vianen W., Bakker-Woudenberg I.A.J.M. Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice. Antimicrob. Agents Chemother. 42:1998;2431-2433
62. van Etten E.W.M., Stearne-Cullen L.E.T., ten Kate M.T., Bakker-Woudenberg I.A.J.M. Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats. Antimicrob. Agents Chemother. 44:2000;540-545
63. Walsh T.J., Yeldandi V., McEvoy M., Gonzalez C., Chanock S., Freifeld A., Seibel N.I., Whitcomb P.O., Jarosinski P., Boswell G., Bekersky I., Alak A., Buell D., Barret J., Wilson W. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob. Agents Chemother. 42:1998;2391-2398
64. Wasan K.M., Lopez-Berestein G. The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol. Immunotoxicol. 17:1995;1-15
65. Whitehead T.C., Lovering A.M., Cropley I.M., Wade P., Davidson R.N. Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;794-797
66. Woodle M.C. Controlling liposome blood clearance by surface-grafted polymers. Adv. Drug Deliv. Rev. 32:1998;139-152
67. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171
68. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., Papahadjopoulos D. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta. 1105:1992;193-200
69. Woodle M.C., Newman M.S., Working P.K. Biological Properties of Sterically Stabilized Liposomes. Lasic D.D., Martin F.J. "Stealth Liposomes" 1995;103-117 CRC Press, Boca Raton, FL